Tags Archive Navigation
icon
-
Media ReleaseSandoz receives positive CHMP opinion for multiple sclerosis biosimilar natalizumab
-
Media ReleaseSandoz to launch Hyrimoz® (adalimumab-adaz) high-concentration formulation, marking Sandoz entrance into US immunology space
-
StoryStopping free radicals at their source
-
StoryNurturing the life science ecosystem
-
StoryHow I built a mini-gut with next to no biology training
-
StoryHow to address the culture gap between academia and industry in biomedicine
-
StoryNovartis and Pfizer join forces to upend oncology dogma
-
StoryNeuroscientists restore cell-to-cell signaling and sociability in autism models
-
StoryEyewitness to a healer pursues new treatments for patients
-
StoryCOVID-19: Answering your top questions
-
StoryChan Zuckerberg Initiative friends Novartis scientist in mission to conquer disease
-
StoryChallenging a young scientist to focus on patients